A significant weapon in the fight against lung cancer may be going to waste, as a survey revealed most Americans aren’t aware ...

Cruising aficionado Jane McDonald sadly lost her partner of 15 years, Eddie Rothe, after a battle with lung cancer – and now she's provided a personal update on ITV ...

A race-neutral algorithm for lung function was recommended last year. Adopting it comes with thorny consequences.

The greatest incidence was seen for metastatic, hematological and lung cancer; an increased risk for CVD was seen with chemotherapy.

There hasn’t been a new class of drugs approved to help smokers quit since Pfizer's Chantix reached the market nearly two ...

New anecdotal evidence suggests some chemoimmunotherapy treatments may improve pulmonary arterial hypertension symptoms, but the overall evidence remains murky.

Over the last century, the U.S. armed forces resorted to asbestos-containing products as WWII demanded accessible materials ...

About 40% of Americans will develop a form of cancer at some point in their lifetime, according to the American Cancer ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

AstraZeneca and Daiichi Sankyo’s TROP2-directed antibody-drug conjugate (ADC) has again failed to improve overall survival ...

AstraZeneca's cancer drug, datopotamab deruxtecan, failed to meet targets in a Phase 3 trial, clouding the possibility of approval from the U.S. Food and Drug Administration. Shares were down 1.2% at ...